D-0186-2025 Class II Ongoing
FDA drug recall D-0186-2025 was initiated by Eugia US LLC on Dec 27, 2024 and is designated Class II. Reason for recall: Presence of Particulate Matter: A market complaint was received of a glass piece in the vial. The recall status is ongoing. Affected quantity: 17,300 10-mL vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 15, 2025
- Initiation Date
- Dec 27, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,300 10-mL vials
Product description
Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10
Reason for recall
Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
Distribution pattern
Distributed Nationwide in the USA.
Code information
Batch # 1PR24010, Expiry: 02/28/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0186-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026